David Rosen, a partner and member of the Life Sciences and Nanotechnology Industry Teams, will be moderating a panel for the Tech Council of Maryland entitled, “Nanomedicine, Opportunities and Challenges.” The session will be taking place at John Hopkins University on September 12, 2007.
The panel will discuss the promises as well as some of the challenges are to creating these new therapies that may be safer and more effective in treating life-threatening diseases.
Panelists include:
- Dr. Hamid Ghandehari, Director, University of Maryland School of Pharmacy, Center for Nanomedicine and Cellular Delivery, Department of Pharmaceutical Sciences
- Dr. Chiming Wei, Department of Surgery, The Johns Hopkins School of Medicine and President, American Academy of Nanomedicine
- Dr. Lawrence Tamarkin, President & CEO, CytImmune Sciences, Inc.
People
Related Insights
May 30, 2025
Foley Career Perspectives
Foley Mental Health Month Program: Enhancing Performance Through High-Quality Connections
Foley & Lardner endeavors to create a high-performance culture that also prioritizes well-being — a culture where every member of the…
May 29, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…
May 29, 2025
Foley Viewpoints
Supreme Court Clarifies Scope of Federal Fraud Statutes in Connection with False DBE Reporting on Federally Funded Projects
On May 22, 2025, the U.S. Supreme Court issued a significant decision in Kousisis v. United States, affirming a six-year prison sentence for a contractor convicted of federal wire fraud for misrepresenting use of a disadvantaged business enterprise supplier on a project.